Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001140361-25-042879
Filing Date
2025-11-20
Accepted
2025-11-20 17:17:10
Documents
25

Document Format Files

Seq Description Document Type Size
1 S-4 ny20057110x1_s4.htm S-4 3658210
2 EXHIBIT 5.1 ny20057110x1_ex5-1.htm EX-5.1 8436
3 EXHIBIT 23.2 ny20057110x1_ex23-2.htm EX-23.2 2074
4 EXHIBIT 23.3 ny20057110x1_ex23-3.htm EX-23.3 1975
5 EXHIBIT 99.2 ny20057110x1_ex99-2.htm EX-99.2 4208
6 EXHIBIT 99.3 ny20057110x1_ex99-3.htm EX-99.3 2991
7 FILING FEE TABLE ny20057110x1_exfees.htm   iXBRL EX-FILING FEES 29474
8 logo_astriax1.jpg GRAPHIC 35335
9 logo_astriax2.jpg GRAPHIC 30133
10 logo_biocrystnewx1.jpg GRAPHIC 18731
11 logo_evercore.jpg GRAPHIC 15894
12 logo_evercoreaddress.jpg GRAPHIC 28962
13 ny20057110x1_ex5-1img001.jpg GRAPHIC 6471
14 ny20057110x1_ex5-1img002.jpg GRAPHIC 3829
15 ny20057110x1_ex5-1img003.jpg GRAPHIC 1597
  Complete submission text file 0001140361-25-042879.txt   4027279

Data Files

Seq Description Document Type Size
27 EXTRACTED XBRL INSTANCE DOCUMENT ny20057110x1_exfees_htm.xml XML 6847
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-291678 | Film No.: 251503940
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)